Fundz

Huma Therapeutics closes $80M in a Series D funding round led by AstraZeneca, Hitachi Ventures, and Bayer to launch a 'Shopify-like' AI digital health platform

Jul 16, 2024

Amount Raised

$80 Million

Round Type

Series D

BiotechnologyHealth CareArtificial IntelligenceMedical

Investors

Leaps By BayerHv Fund By Hitachi VenturesHat Technology Fund 4Astra Zeneca

Description

Huma Therapeutics has closed a $80M Series D funding round, bringing the total funding raised to $300 million. The round saw participation from AstraZeneca, Hat Technology Fund 4, HV Fund by Hitachi Ventures, Leaps by Bayer, and others. In addition, the company has launched Huma Cloud Platform, a GenAI-powered 'Shopify-like' experience for the digital health ecosystem.

Quick answer

Huma Therapeutics raised $80 Million in a Series D round, dated July 16, 2024. Investors: Leaps By Bayer, Hv Fund By Hitachi Ventures, Hat Technology Fund 4 and Astra Zeneca.

How much did Huma Therapeutics raise?
Huma Therapeutics raised $80 Million in a Series D round on July 16, 2024.
Who invested in Huma Therapeutics?
Leaps By Bayer, Hv Fund By Hitachi Ventures, Hat Technology Fund 4 and Astra Zeneca are named as investors in this round.
What does Huma Therapeutics do?
Huma Therapeutics is a healthcare AI company focused on accelerating the adoption of digital solutions in care and research.
Where is Huma Therapeutics based and how big is it?
Fundz records about 217 employees.
Who are the decision-makers at Huma Therapeutics?
Fundz holds 1 contact at Huma Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as Huma Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • SoundHealth raised $7M (Seed) on July 24, 2024.
  • Spotlight Medical raised $6.7M (Seed) on July 12, 2024.
  • MedReddie raised $782K (Pre-Seed) on July 12, 2024.
  • AIRS Medical raised $20M (Series C) on July 10, 2024.
  • i'SUPPLY raised $2.5M (Pre-Series A) on June 11, 2024.
  • Ordaos raised $3.1M (Seed) on August 29, 2024.

Who to call at Huma Therapeutics, and when

A new round usually means Huma Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Huma Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Huma Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Huma Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Huma Therapeutics

About

Huma Therapeutics is a healthcare AI company focused on accelerating the adoption of digital solutions in care and research. Their technology powers multi-channel patient engagement at population-wide scale for healthcare systems, remote patient monitoring (RPM) at scale, companion apps to support patients through treatment and drug therapies, and digital clinical trials to accelerate medical research.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Huma Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Huma Therapeutics's next move

See what Strategic adds

Huma Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.